Literature DB >> 16849317

RACK1 binds to Smad3 to modulate transforming growth factor-beta1-stimulated alpha2(I) collagen transcription in renal tubular epithelial cells.

Kazuhiro Okano1, H William Schnaper, Karol Bomsztyk, Tomoko Hayashida.   

Abstract

Although it is clear that transforming growth factor-beta1 (TGF-beta1) is critical for renal fibrogenesis, the complexity of the involved mechanisms is increasingly apparent. TGF-beta1 stimulates phosphorylation of Smad2/3 and activates other signaling molecules as well. The molecular link between these other kinases and Smads is not known. We sought new binding partners for Smad3 in renal cells and identified receptor for activated protein kinase C 1 (RACK1) as a novel binding partner of Smad3. The linker region of Smad3 and the tryptophan-aspartic acid repeat 6 and 7 of RACK1 are sufficient for the association. RACK1 also interacts with Smad3 in the human kidney epithelial cell line, HKC. Silencing RACK1 increases transcriptional activity of TGF-beta1-responsive promoter sequences of the Smad binding element (SBE), p3TP-Lux, and alpha2(I) collagen. Conversely, overexpressed RACK1 negatively modulates alpha2(I) collagen transcriptional activity in TGF-beta1-stimulated cells. RACK1 did not affect phosphorylation of Smad3 at the C terminus or in the linker region. However, RACK1 reduced direct binding of Smad3 to the SBE motif. Mutating a RACK1 tyrosine at residue 246, but not at 228, decreased the inhibitory effect of RACK1 on both alpha2(I) collagen promoter activity and Smad binding to SBE induced by TGF-beta1. These results suggest that RACK1 modulates transcription of alpha2(I) collagen by TGF-beta1 through interference with Smad3 binding to the gene promoter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849317     DOI: 10.1074/jbc.M606710200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A novel interaction between Glycogen Synthase Kinase-3α (GSK-3α) and the scaffold protein Receptor for Activated C-Kinase 1 (RACK1) regulates the circadian clock.

Authors:  Leigh C Zeidner; Jessica L Buescher; Christopher J Phiel
Journal:  Int J Biochem Mol Biol       Date:  2011-11-20

2.  Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer.

Authors:  Andrei V Chernov; Svetlana Baranovskaya; Vladislav S Golubkov; Dustin R Wakeman; Evan Y Snyder; Roy Williams; Alex Y Strongin
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

3.  The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.

Authors:  Swati Bhattacharyya; Jun Wei; Denisa S Melichian; Jeffrey Milbrandt; Kazuhiko Takehara; John Varga
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

4.  Notch4-dependent antagonism of canonical TGF-β1 signaling defines unique temporal fluctuations of SMAD3 activity in sheared proximal tubular epithelial cells.

Authors:  Bryan M Grabias; Konstantinos Konstantopoulos
Journal:  Am J Physiol Renal Physiol       Date:  2013-04-10

5.  RACK1 is involved in endothelial barrier regulation via its two novel interacting partners.

Authors:  Anita Boratkó; Pál Gergely; Csilla Csortos
Journal:  Cell Commun Signal       Date:  2013-01-11       Impact factor: 5.712

6.  The RACK1 signal anchor protein from Trypanosoma brucei associates with eukaryotic elongation factor 1A: a role for translational control in cytokinesis.

Authors:  Sandesh Regmi; Karen G Rothberg; James G Hubbard; Larry Ruben
Journal:  Mol Microbiol       Date:  2008-09-10       Impact factor: 3.501

7.  The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.

Authors:  Michaël Ruff; Anthony Leyme; Fabienne Le Cann; Dominique Bonnier; Jacques Le Seyec; Franck Chesnel; Laurent Fattet; Ruth Rimokh; Georges Baffet; Nathalie Théret
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.